Anti-tetherin activities of HIV-1 Vpu and ebola virus glycoprotein do not involve removal of tetherin from lipid rafts

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5467-5480

  Lopez, Lisa A ^a   Yang, Su Jung ^a   Exline, Colin M ^a   Rengarajan, Srinivas ^a   Haworth, Kevin G ^a   Cannon, Paula M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HOST FACTOR; TETHERIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VPU PROTEIN;

ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRUS ASSEMBLY; VIRUS LIKE AGENT; VIRUS PARTICLE;

ANTIGENS, CD; CELL LINE; EBOLAVIRUS; GPI-LINKED PROTEINS; HEMORRHAGIC FEVER, EBOLA; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LIPID BILAYERS; MEMBRANE MICRODOMAINS; PROTEIN BINDING; PROTEIN TRANSPORT; VIRAL ENVELOPE PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84860837223     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06280-11     Document Type: Article

References (96)

1. Abada P, Noble B, Cannon PM. 2005. Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J. Virol. 79:3627-3638.
2. Andrew AJ, Miyagi E, Kao S, Strebel K. 2009. The formation of cysteinelinked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology 6:80.
3. Andrew AJ, Kao S, Strebel K. 2011. C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif. J. Biol. Chem. 286:39967- 39981.
4. Bartee E, McCormack A, Fruh K. 2006. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2:e107.
5. Bavari S, et al. 2002. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195: 593-602.
6. Bohn W, Rutter G, Hohenberg H, Mannweiler K, Nobis P. 1986. Involvement of actin-filaments in budding of measles virus-studies on cytoskeletons of infected cells. Virology 149:91-106.
7. Briggs JA, Wilk T, Fuller SD. 2003. Do lipid rafts mediate virus assembly and pseudotyping? J. Gen. Virol. 84:757-768.
8. Brown DA, Rose JK. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533-544.
9. Brown DA, London E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275:17221-17224.
10. Brown DA. 2002. Isolation and use of rafts. Curr. Protoc. Immunol. 11:11.10.
11. Brown DA. 2006. Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 21:430-439.
12. Chamberlain LH. 2004. Detergents as tools for the purification and classification of lipid rafts. FEBS Lett. 559:1-5.
13. Chazal N, Gerlier D. 2003. Virus entry, assembly, budding, and membrane rafts. Microbiol. Mol. Biol. Rev. 67:226 -237.
14. Derdowski A, Ding LM, Spearman P. 2004. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55(Gag)I domain mediates Gag-Gag interactions. J. Virol. 78:1230 -1242.
15. Dolnik O, et al. 2004. Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J. 23:2175-2184.
16. Dolnik O, Kolesnikova L, Becker S. 2008. Filoviruses: interactions with the host cell. Cell. Mol. Life Sci. 65:756 -776.
17. Douglas JL, et al. 2009. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a _TrCPdependent mechanism. J. Virol. 83:7931-7947.
18. Dube M, et al. 2010. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 6:e1000856.
19. Fitzpatrick K, et al. 2010. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog. 6:e1000701.
20. Francica JR, Matukonis MK, Bates P. 2009. Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. Virology 383:237-247.
21. Fritz JV, Tibroni N, Keppler OT, Fackler OT. 2012. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/tetherin. Virology 424:33- 44.
22. Fullekrug J, Shevchenko A, Shevchenko A, Simons K. 2006. Identification of glycosylated marker proteins of epithelial polarity in MDCK cells by homology driven proteomics. BMC Biochem. 7:8.
23. Funke C, Becker S, Dartsch H, Klenk HD, Muhlberger E. 1995. Acylation of the Marburg virus glycoprotein. Virology 208:289 -297.
24. Garner AE, Smith DA, Hooper NM. 2008. Visualization of detergent solubilization of membranes: implications for the isolation of rafts. Biophys. J. 94:1326 -1340.
25. Goffinet C, et al. 2009. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5:285-297.
26. Gupta RK, et al. 2009. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 5:e1000443.
27. Gupta RK, et al. 2009. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc. Natl. Acad. Sci. U. S. A. 106:20889 -20894.
28. Habermann A, et al. 2010. CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J. Virol. 84:4646-4658.
29. Hammonds J, Wang JJ, Yi H, Spearman P. 2010. Immunoelectron microscopic evidence for tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog. 6:e1000749.
30. Hannan LA, Edidin M. 1996. Traffic, polarity, and detergent solubility of a glycosylphosphatidylinositol-anchored protein after LDL-deprivation of MDCK cells. J. Cell Biol. 133:1265-1276.
31. Harder T, Scheiffele P, Verkade P, Simons K. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141:929 -942.
32. Harty RN, Brown ME, Wang GL, Huibregtse J, Hayes FP. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U. S. A. 97:13871-13876.
33. Hauser H, et al. 2010. HIV-1 Vpu and HIV-2 Env counteract BST-2/ tetherin by sequestration in a perinuclear compartment. Retrovirology 7:51.
34. Hein Z, Hooper NM, Naim HY. 2009. Association of a GPI-anchored protein with detergent-resistant membranes facilitates its trafficking through the early secretory pathway. Exp. Cell Res. 315:348 -356.
35. Holm K, Weclewicz K, Hewson R, Suomalainen M. 2003. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J. Virol. 77:4805- 4817.
36. Hooper NM, Turner AJ. 1988. Ectoenzymes of the kidney microvillar membrane. Differential solubilization by detergents can predict a glycosyl-phosphatidylinositol membrane anchor. Biochem. J. 250:865- 869.
37. Hooper NM. 1999. Detergent-insoluble glycosphingolipid/cholesterolrich membrane domains, lipid rafts and caveolae (review). Mol. Membr. Biol. 16:145-156.
38. Ito H, Watanabe S, Takada A, Kawaoka Y. 2001. Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75:1576 -1580.
39. Janes PW, Ley SC, Magee AI. 1999. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147:447- 461.
40. Jasenosky LD, Neumann G, Lukashevich I, Kawaoka Y. 2001. Ebola virus VP40-induced particle formation and association with the lipid bilayer. J. Virol. 75:5205-5214.
41. Jeffers SA, Sanders DA, Sanchez A. 2002. Covalent modifications of the Ebola virus glycoprotein. J. Virol. 76:12463-12472.
42. Jia B, et al. 2009. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 5:e1000429.
43. Jouvenet N, et al. 2009. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83:1837-1844.
44. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. 2009. Tetherinmediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 106:2886 -2891.
45. Klein U, Gimpl G, Fahrenholz F. 1995. Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34:13784- 13793.
46. Kueng HJ, Schmetterer KG, Pickl WF. 2011. Lipid rafts, pseudotyping, and virus-like particles: relevance of a novel, configurable, and modular antigen-presenting platform. Int. Arch. Allergy Immunol. 154:89 -110.
47. Kupzig S, et al. 2003. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4:694 -709.
48. Le Tortorec A, Neil SJ. 2009. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83:11966 -11978.
49. Leung K, et al. 2008. HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions. Cell Host Microbe 3:285-292.
50. Licata JM, et al. 2003. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J. Virol. 77: 1812-1819.
51. Licata JM, Johnson RF, Han Z, Harty RN. 2004. Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 viruslike particles. J. Virol. 78:7344 -7351.
52. Lindwasser OW, Resh MD. 2001. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75:7913-7924.
53. Lipardi C, Nitsch L, Zurzolo C. 2000. Detergent-insoluble GPI-anchored proteins are apically sorted in fischer rat thyroid cells, but interference with cholesterol or sphingolipids differentially affects detergent insolubility and apical sorting. Mol. Biol. Cell 11:531-542.
54. Lopez LA, et al. 2010. Ebola virus glycoprotein counteracts BST-2/ tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J. Virol. 84:7243-7255.
55. Mangeat B, et al. 2009. HIV-1 Vpu neutralizes the antiviral factor tetherin/ BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 5:e1000574.
56. Mansouri M, et al. 2009. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 83:9672-9681.
57. Masuyama N, et al. 2009. HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin. J. Biol. Chem. 284:15927-15941.
58. Mehedi M, et al. 2011. A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J. Virol. 85:5406 -5414.
59. Melkonian KA, Chu T, Tortorella LB, Brown DA. 1995. Characterization of proteins in detergent-resistant membrane complexes from Madin-Darby canine kidney epithelial cells. Biochemistry 34:16161-16170.
60. Mitchell RS, et al. 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5:e1000450.
61. Miyagi E, Andrew AJ, Kao S, Strebel K. 2009. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U. S. A. 106:2868 -2873.
62. Morrison TG, Mcginnes LJ. 1985. Cytochalasin-D accelerates the release of Newcastle disease virus from infected cells. Virus Res. 4:93-106.
63. Nebl T, et al. 2002. Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J. Biol. Chem. 277:43399- 43409.
64. Neil SJ, Zang T, Bieniasz PD. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425- 430.
65. Neufeld EB, et al. 1996. Intracellular trafficking of cholesterol monitored with a cyclodextrin. J. Biol. Chem. 271:21604 -21613.
66. Nguyen DH, Hildreth JE. 2000. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74:3264 -3272.
67. Nguyen KL, et al. 2004. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Revindependent expression. Virology 319:163-175.
68. Nichols B. 2003. Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116:4707- 4714.
69. Ohtani Y, Irie T, Uekama K, Fukunaga K, Pitha J. 1989. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur. J. Biochem. 186:17-22.
70. Ono A, Freed EO. 2001. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 98:13925- 13930.
71. Ono A, Waheed AA, Joshi A, Freed EO. 2005. Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel gag multimerization assay. J. Virol. 79:14131-14140.
72. Ostermeyer AG, Beckrich BT, Ivarson KA, Grove KE, Brown DA. 1999. Glycosphingolipids are not essential for formation of detergent-resistant membrane rafts in melanoma cells-methyl-beta-cyclodextrin does not affect cell surface transport of a GPI-anchored protein. J. Biol. Chem. 274:34459 -34466.
73. Panchal RG, et al. 2003. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc. Natl. Acad. Sci. U. S. A. 100:15936 -15941.
74. Perez-Caballero D, et al. 2009. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139:499 -511.
75. Radoshitzky SR, et al. 2010. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J. Virol. 84:10569 -10580.
76. Reynard O, et al. 2009. Ebola virus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J. Virol. 83:9596- 9601.
77. Rollason R, Korolchuk V, Hamilton C, Jepson M, Banting G. 2009. A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. J. Cell Biol. 184:721-736.
78. Ruiz A, Hill MS, Schmitt K, Stephens EB. 2010. Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release. Virology 408:89 -102.
79. Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J. 2009. Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 83:2382-2385.
80. Sanchez A, et al. 1998. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72:6442- 6447.
81. Sanderson CM, Avalos R, Kundu A, Nayak DP. 1995. Interaction of Sendai viral F, HN, and M proteins with host cytoskeletal and lipid components in Sendai virus-infected BHK cells. Virology 209:701-707.
82. Sauter D, et al. 2009. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6:409-421.
83. Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K. 2003. Resistance of cell membranes to different detergents. Proc. Natl. Acad. Sci. U. S. A. 100:5795-5800.
84. Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. 2002. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J. Virol. 76:2518 -2528.
85. Stulnig TM, et al. 1998. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J. Cell Biol. 143:637- 644.
86. Suomalainen M. 2002. Lipid rafts and assembly of enveloped viruses. Traffic 3:705-709.
87. Takada A, et al. 2000. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278:20 -26.
88. Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. 2007. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J. Infect. Dis. 196:S347-S356.
89. Van Damme N, et al. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3:245-252.
90. van Meer G, Simons K. 1988. Lipid polarity and sorting in epithelial cells. J. Cell Biochem. 36:51-58.
91. Varthakavi V, et al. 2006. The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release. Traffic 7:298 -307.
92. Volchkov VE, Volchkova VA, Slenczka W, Klenk HD, Feldmann H. 1998. Release of viral glycoproteins during Ebola virus infection. Virology 245:110 -119.
93. Volchkova VA, Feldmann H, Klenk HD, Volchkov VE. 1998. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology 250:408-414.
94. Yang SJ, et al. 2010. Anti-tetherin activities in Vpu-expressing primate lentiviruses. Retrovirology 7:13.
95. Yang ZY, et al. 2000. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6:886-889.
96. Zhang F, et al. 2009. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6:54-67.